Published in J Am Coll Cardiol on February 04, 2004
Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol (2010) 1.81
Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet J Rare Dis (2013) 1.68
CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis. JACC Cardiovasc Imaging (2014) 1.57
Transthyretin (TTR) cardiac amyloidosis. Circulation (2012) 1.40
Transthyretin cardiac amyloidoses in older North Americans. J Am Geriatr Soc (2012) 1.03
Amyloid in endomyocardial biopsies. Virchows Arch (2010) 1.00
Identifying the etiology: a systematic approach using delayed-enhancement cardiovascular magnetic resonance. Heart Fail Clin (2009) 0.96
The role of cardiac magnetic resonance imaging in differentiating the underlying causes of left ventricular hypertrophy. Neth Heart J (2010) 0.93
Incidence, diagnosis and prognosis of cardiac amyloidosis. Korean Circ J (2013) 0.90
How to image cardiac amyloidosis. Circ Cardiovasc Imaging (2014) 0.89
Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. Eur Radiol (2011) 0.89
Impact of regional left ventricular function on outcome for patients with AL amyloidosis. PLoS One (2013) 0.85
Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor. Clin Res Cardiol (2014) 0.84
Case report: isolated cardiac amyloidosis: an enigma unravelled. Methodist Debakey Cardiovasc J (2015) 0.80
CT and MRI evaluation of cardiac complications in patients with hematologic diseases: a pictorial review. Int J Cardiovasc Imaging (2015) 0.78
Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (2013) 0.77
Recent advances in the noninvasive strategies of cardiac amyloidosis. Heart Fail Rev (2016) 0.77
Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration. Int J Cardiovasc Imaging (2012) 0.76
Stiff heart syndrome. Clin Med Res (2010) 0.76
Case 4 - A 79-Year-Old Man with Congestive Heart Failure Due to Restrictive Cardiomyopathy. Arq Bras Cardiol (2015) 0.75
Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy. J Am Soc Echocardiogr (2014) 0.75
A patient with progressive dyspnoea. Neth Heart J (2015) 0.75
Frequency of Cardiovascular Involvement in Familial Amyloidotic Polyneuropathy in Brazilian Patients. Arq Bras Cardiol (2015) 0.75
Amyloid in biopsies of the gastrointestinal tract-a retrospective observational study on 542 patients. Virchows Arch (2016) 0.75
Embolic infarction associated with cardiac amyloidosis. J Clin Neurol (2005) 0.75
Isolated cardiac involvement in primary amyloidosis: presenting as sick sinus syndrome and heart failure. Tex Heart Inst J (2013) 0.75
Case 3/2014--81-year-old patient hospitalized for decompensated heart failure. Arq Bras Cardiol (2014) 0.75
Nephrotic syndrome: A twist in the tail. Indian J Nephrol (2008) 0.75
Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea. J Cardiovasc Ultrasound (2012) 0.75
Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy. Open Heart (2016) 0.75
A Case of Cardiac Amyloidosis Initially Misdiagnosed as Syndrome X. Cardiol Res (2011) 0.75
Application of cardiac magnetic resonance imaging in cardiomyopathy. Curr Heart Fail Rep (2008) 0.75
Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma. Am J Case Rep (2017) 0.75
Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy. Heart Vessels (2016) 0.75
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart (2017) 0.75
Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med (2005) 17.61
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation (2007) 8.62
FGF23 induces left ventricular hypertrophy. J Clin Invest (2011) 7.22
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med (2005) 6.50
Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A (2005) 6.16
Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87
Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res (2010) 5.47
Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res (2011) 4.75
Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell (2003) 4.42
Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med (2007) 4.30
Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A (2009) 4.21
In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation (2003) 4.00
Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature (2002) 3.92
2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 3.86
Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation (2003) 3.30
Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA (2003) 3.25
Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res (2011) 3.23
Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load. J Clin Invest (2005) 3.22
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol (2003) 3.19
Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation (2003) 3.01
Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation (2003) 2.68
Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Am J Respir Crit Care Med (2013) 2.66
Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res (2007) 2.62
Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation (2012) 2.57
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50
Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res (2003) 2.44
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials. JAMA (2004) 2.44
Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging (2009) 2.41
Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care (2003) 2.38
Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension (2005) 2.37
Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol (2005) 2.30
Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J (2009) 2.29
Prospective evaluation of pain and analgesic use following major elective intracranial surgery. J Neurosurg (2007) 2.26
L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA (2006) 2.24
Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Circulation (2008) 2.15
Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci U S A (2009) 2.13
Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol (2006) 2.10
Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant (2004) 2.09
Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation (2006) 2.07
Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med (2007) 2.07
Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res (2005) 2.05
Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res (2011) 2.02
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med (2007) 1.98
Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol (2008) 1.97
Changing preferences for survival after hospitalization with advanced heart failure. J Am Coll Cardiol (2008) 1.96
Obesity impacts access to kidney transplantation. J Am Soc Nephrol (2007) 1.95
Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A (2004) 1.91
Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . Circulation (2006) 1.87
2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol (2009) 1.86
Molecular testing in the management of cardiac transplant recipients: initial clinical experience. J Heart Lung Transplant (2006) 1.84
Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J (2004) 1.84
Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A (2007) 1.79
Computer-based documentation: effects on parent-provider communication during pediatric health maintenance encounters. Pediatrics (2008) 1.78
The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. Eur Heart J (2009) 1.73
Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res (2002) 1.70
Kindergarten Predictors of Math Learning Disability. Learn Disabil Res Pract (2005) 1.69
Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry (2004) 1.67
Efficacy of intravenous patient-controlled analgesia after supratentorial intracranial surgery: a prospective randomized controlled trial. Clinical article. J Neurosurg (2009) 1.64
Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. JACC Cardiovasc Imaging (2011) 1.63
Intrapartum electronic fetal heart rate monitoring and the identification of metabolic acidosis and hypoxic-ischemic encephalopathy. Am J Obstet Gynecol (2007) 1.61
Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol (2005) 1.61
Interventional cardiology perspective of functional tricuspid regurgitation. Circ Cardiovasc Interv (2009) 1.61
Prolonged waiting times for liver transplantation in obese patients. Ann Surg (2008) 1.57
Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics (2005) 1.54
Mesenchymal stem cells: future source for reparative medicine. Congest Heart Fail (2005) 1.53
Paragangliomas: etiology, presentation, and management. Cardiol Rev (2009) 1.52
Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol (2008) 1.52
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr (2013) 1.51
Effect of Beta-blocker therapy on rehospitalization rates in women versus men with heart failure and preserved ejection fraction. Am J Cardiol (2010) 1.51
Clinical and electrophysiologic patterns of flaccid paralysis due to West Nile virus. Mayo Clin Proc (2003) 1.48
Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48
Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation (2004) 1.47
Myocardial infarction and intramyocardial injection models in swine. Nat Protoc (2012) 1.47
Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A (2003) 1.44
Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction. Hypertension (2004) 1.44
Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol (2009) 1.44
Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction. Clin Transl Sci (2011) 1.43
Quantitative automated assessment of myocardial perfusion at cardiac catheterization. Am J Cardiol (2008) 1.43
Risk Factors for Venous Thromboembolism in Pediatric Trauma Patients and Validation of a Novel Scoring System: The Risk of Clots in Kids With Trauma Score. Pediatr Crit Care Med (2016) 1.42
A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol (2003) 1.42
Prognostic value of troponin I levels for predicting adverse cardiovascular outcomes in postmenopausal women undergoing cardiac surgery. Anesth Analg (2009) 1.41